Skip to main content
. 2017 Sep 21;33(1):35–41. doi: 10.1177/1533317517728352

Figure 2.

Figure 2.

Apolipoprotein E (ApoE) ε4 carrier status, both homo- and heterozygosity, did not significantly differ between Alzheimer’s disease with mild dementia (AD), mild cognitive impairment due to AD (MCI-AD), and healthy controls (HC).